Evidence map›Paper›PMID 28767704›Full record

ArticlePLoS pathogens2017

B. abortus RNA is the component involved in the down-modulation of MHC-I expression on human monocytes via TLR8 and the EGFR pathway.

M Ayelén Milillo, Lis N Velásquez, Aldana Trotta, M Victoria Delpino, Fábio V Marinho, Luciana Balboa, Mónica Vermeulen, Sonia L Espindola, Nahuel Rodriguez-Rodrigues, Gabriela C Fernández and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Cells · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Frontiers in cellular and infection microbiology · 2024
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Modulation of Microtubule Dynamics AffectsFrontiers in microbiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

M Ayelén MililloInstituto de Medicina Experimental (CONICET-Academia Nacional de Medicina), Buenos Aires, Argentina.
Lis N VelásquezInstituto de Medicina Experimental (CONICET-Academia Nacional de Medicina), Buenos Aires, Argentina.
Aldana TrottaInstituto de Medicina Experimental (CONICET-Academia Nacional de Medicina), Buenos Aires, Argentina.
M Victoria DelpinoInstituto de Inmunología, Genética y Metabolismo (CONICET-UBA), Laboratorio de Inmunogenética, Buenos Aires, Argentina.
Fábio V MarinhoDepartamento de Bioquímica e Imunologia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.ORCID http://orcid.org/0000-0001-6885-3438
Luciana BalboaInstituto de Medicina Experimental (CONICET-Academia Nacional de Medicina), Buenos Aires, Argentina.
Mónica VermeulenInstituto de Medicina Experimental (CONICET-Academia Nacional de Medicina), Buenos Aires, Argentina.
Sonia L EspindolaInstituto de Investigaciones en Ingeniería Genética y Biología Molecular (INGEBI), CONICET, Buenos Aires, Argentina.
Nahuel Rodriguez-RodriguesInstituto de Medicina Experimental (CONICET-Academia Nacional de Medicina), Buenos Aires, Argentina.
Gabriela C FernándezInstituto de Medicina Experimental (CONICET-Academia Nacional de Medicina), Buenos Aires, Argentina.
Sergio Costa OliveiraDepartamento de Bioquímica e Imunologia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
Guillermo H GiambartolomeiInstituto de Inmunología, Genética y Metabolismo (CONICET-UBA), Laboratorio de Inmunogenética, Buenos Aires, Argentina.
Paula BarrionuevoInstituto de Medicina Experimental (CONICET-Academia Nacional de Medicina), Buenos Aires, Argentina.ORCID http://orcid.org/0000-0002-4940-4263
Academia Nacional de Medicina · ARInstitute of Astronomy and Space Physics · ARUniversidade Federal de Minas Gerais · BRConsejo Nacional de Investigaciones Científicas y Técnicas · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite eliciting a potent CD8+ T cell response, Brucella abortus is able to persist and establish a chronic infection inside its host. We have previously reported that the infection of human monocytes/macrophages with B. abortus inhibits the IFN-γ-induced MHC-I cell surface expression down-modulating cytotoxic CD8+ T cell responses. MHC-I down-modulation depends on bacterial viability and results from the capacity of B. abortus to retain the MHC-I molecules within the Golgi apparatus. Furthermore, we recently demonstrated that epidermal growth factor receptor (EGFR) pathway is involved in this phenomenon and that this is an early event during infection. However, the components and mechanisms whereby B. abortus is able to down-modulate MHC-I remained to be elucidated. In this study we demonstrated that the down-modulation of MHC-I expression is not mediated by well-known Brucella virulence factors but instead by B. abortus RNA, a PAMP associated to viability (vita-PAMP). Surprisingly, completely degraded RNA was also able to inhibit MHC-I expression to the same extent as intact RNA. Accordingly, B. abortus RNA and its degradation products were able to mimic the MHC-I intracellular retention within the Golgi apparatus observed upon infection. We further demonstrated that TLR8, a single-stranded RNA and RNA degradation products sensor, was involved in MHC-I inhibition. On the other hand, neutralization of the EGFR reversed the MHC-I inhibition, suggesting a connection between the TLR8 and EGFR pathways. Finally, B. abortus RNA-treated macrophages display diminished capacity of antigen presentation to CD8+ T cells. Overall, our results indicate that the vita-PAMP RNA as well as its degradation products constitute novel virulence factors whereby B. abortus, by a TLR8-dependent mechanism and through the EGFR pathway, inhibits the IFN-γ-induced MHC-I surface expression on human monocytes/macrophages. Thus, bacteria can hide within infected cells and avoid the immunological surveillance of cytotoxic CD8+ T cells.

Indexed as

AnimalsBrucella abortusBrucellosisCross-PrimingDown-RegulationEnzyme-Linked Immunosorbent AssayErbB ReceptorsFlow CytometryHistocompatibility Antigens Class IHumansImmune EvasionMiceMice, Inbred C57BLMicroscopy, ConfocalMonocytesRNA, BacterialEGFR protein, humanErbB ReceptorsHistocompatibility Antigens Class IRNA, BacterialTLR8 protein, humanToll-Like Receptor 8

Identifiers

PMID28767704
PMCPMC5540288
OpenAlexW2739854818

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.